# Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

> **NCT07505446** · — · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Multi Drug Resistant Organisms
- Antibiotic Resistance

## Interventions

- **DRUG:** verapamil

## Key facts

- **NCT ID:** NCT07505446
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07505446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07505446, "Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07505446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*